BioMetal Health has raised $1.0M in funding from the Draper Family. The company makes patented metal implants designed to dissolve at a controlled rate, speeding bone and tissue regeneration while fighting infection and inflammation over a period of years.
The round rests on 15 years of research and $5.5M in non-dilutive grants, according to the company. BioMetal is aiming at the roughly 30 million Americans with back pain and 160 million with cardiovascular disease, and says the new capital will go toward scaling its U.S.-based manufacturing.
